Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine companies.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
2018
Hereditary angioedema patient Machelle on why her rare disease can't hold her back.
Jesse Schrader’s Promising Tips for balancing hemophilia with "being dad."
A look inside CSL Behring’s leading-edge Illinois manufacturing site.
Pro golfer Perry Parker on learning resilience through living with his rare disease.
Webinar offers rare disease patients a chance to ask questions about insurance plans.
Why CSL Behring is exploring new treatment options for this rare disease.
What people living with hemophilia need to know.
More heads are better than one.
Weakness, numbness and tingling in the arms and legs may be symptoms of CIDP.
Americas
Asia Pacific
Middle East
Europe
